Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mG
published in: Molecular Pharmacology
date of publication: 2010-12-15
main subject: Alzheimer's disease, psychosis
Cites articles
There is nothing here
Article - wd:Q45356884